We can't find the internet
Attempting to reconnect
Something went wrong!
Hang in there while we get back on track
The hidden poison - microplastic : Inflammatory catalyst of cancer development
Summary
This review discusses how microplastics act as inflammatory agents within biological tissues, summarizing evidence that ingested and inhaled microplastics can trigger oxidative stress, immune responses, and chronic inflammation in humans and animals.
Microplastics, tiny plastic particles less than 5 millimeters in diameter, have become a growing concern due to their widespread presence in various ecosystems and their potential health impacts, particularly their role in inducing inflammation and contributing to cancer development. This paper explores the mechanisms through which microplastics trigger inflammatory responses in biological systems, leading to oxidative stress, cellular damage, and disruptions in cellular signaling pathways. These processes not only sustain chronic inflammation but also create a microenvironment conducive to tumor initiation and progression. The paper further discusses the global prevalence of microplastic pollution, the specific inflammatory pathways activated by microplastics, and the resulting implications for various types of cancer, including gastrointestinal, lung, liver, skin, and breast cancers. The study highlights the urgent need for standardized research methodologies, long-term studies, and effective remediation strategies to mitigate the health risks posed by microplastic exposure.
Sign in to start a discussion.
More Papers Like This
Microplastics: an often-overlooked issue in the transition from chronic inflammation to cancer
This review explores how microplastics that accumulate in the human body may trigger long-lasting inflammation, which is a known driver of cancer development. The authors describe how microplastics can disrupt the gut microbiome, activate immune responses, and alter signaling pathways in ways that could promote tumor growth over time.
Microscopic menace: exploring the link between microplastics and cancer pathogenesis
This review examines the growing evidence linking microplastic exposure to cancer development in humans. Microplastics can accumulate in the body and trigger inflammation, oxidative stress, and other biological changes associated with tumor growth. While more clinical research is needed, the review highlights that microplastics should be taken seriously as a potential factor in cancer risk.
From Exposure to Oncogenesis: the Role of Microplastics and Associated Pollutants in Cancer - a Literature Review
This literature review examined the growing evidence linking microplastic exposure to cancer development. Microplastics have been found in human lung, liver, and colon tissue, and research suggests they may promote cancer through chronic inflammation, oxidative stress, and by carrying known carcinogens like heavy metals and persistent organic pollutants into the body.
Microplastics as emerging carcinogens: from environmental pollutants to oncogenic drivers
This review examines growing evidence that microplastics and nanoplastics may play a role in cancer development, with these particles found in human tumor tissues from the lungs, colon, stomach, breast, and other organs. The particles appear to promote cancer through chronic inflammation, oxidative stress, DNA damage, and disruption of key cancer-related signaling pathways. While direct proof of causation in humans is still lacking, the accumulating evidence from lab studies, animal experiments, and human tissue analysis suggests microplastics deserve serious attention as potential contributors to cancer risk.
The micro(nano)plastics perspective: exploring cancer development and therapy
This review explores the emerging link between microplastics and cancer development. Microplastics can trigger chronic inflammation, oxidative stress, and hormone disruption, all of which are known pathways that may promote cancer growth. Interestingly, researchers are also studying whether engineered microplastics could be used as drug carriers for cancer therapy, though long-term effects remain unclear.